BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7165698)

  • 1. Evidence that enteroglucagon (II) is identical with the C-terminal sequence (residues 33-69) of glicentin.
    Holst JJ
    Biochem J; 1982 Dec; 207(3):381-8. PubMed ID: 7165698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that glicentin contains the entire sequence of glucagon.
    Holst JJ
    Biochem J; 1980 May; 187(2):337-43. PubMed ID: 6893148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biological significance of "enteroglucagon." Present status.
    Bataille D; Jarrousse C; Kervran A; Depigny C; Dubrasquet M
    Peptides; 1986; 7 Suppl 1():37-42. PubMed ID: 3529053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The primary structure of porcine glicentin (proglucagon).
    Thim L; Moody AJ
    Regul Pept; 1981 May; 2(2):139-50. PubMed ID: 6894800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and sequence of rat oxyntomodulin.
    Collie NL; Walsh JH; Wong HC; Shively JE; Davis MT; Lee TD; Reeve JR
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9362-6. PubMed ID: 7937770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proglucagon processing in porcine and human pancreas.
    Holst JJ; Bersani M; Johnsen AH; Kofod H; Hartmann B; Orskov C
    J Biol Chem; 1994 Jul; 269(29):18827-33. PubMed ID: 8034635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon-related peptides in the human gastrointestinal mucosa.
    Baldissera FG; Holst JJ
    Diabetologia; 1984 Mar; 26(3):223-8. PubMed ID: 6546922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glicentin 1-61 probably represents a major fraction of glucagon-related peptides in plasma of anaesthetized uraemic pigs.
    Baldissera FG; Holst JJ
    Diabetologia; 1986 Jul; 29(7):462-7. PubMed ID: 3743926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular forms of glucagon-like immunoreactivity in porcine intestine and pancreas.
    Ghatei MA; Uttenthal LO; Bryant MG; Christofides ND; Moody AJ; Bloom SR
    Endocrinology; 1983 Mar; 112(3):917-23. PubMed ID: 6822217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The amino acid sequence of porcine glicentin.
    Thim L; Moody AJ
    Peptides; 1981; 2 Suppl 2():37-9. PubMed ID: 7045833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an oxyntomodulin/glicentin C-terminal radioimmunoassay using a "thiol-maleoyl" coupling method for preparing the immunogen.
    Blache P; Kervran A; Martinez J; Bataille D
    Anal Biochem; 1988 Aug; 173(1):151-9. PubMed ID: 3189794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bioactive "enteroglucagon" (oxyntomodulin): evidence for a C-terminal extension of the glucagon molecule].
    Bataille D; Tatemoto K; Coudray AM; Rosselin G; Mutt V
    C R Seances Acad Sci III; 1981 Oct; 293(6):323-8. PubMed ID: 6797684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enteroglucagon.
    Holst JJ
    Annu Rev Physiol; 1997; 59():257-71. PubMed ID: 9074764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboxypeptidase-B-like processing of the C-terminus of glucagon-like peptide-2 in pig and human small intestine.
    Orskov C; Buhl T; Rabenhøj L; Kofod H; Holst JJ
    FEBS Lett; 1989 Apr; 247(2):193-6. PubMed ID: 2714431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of oxyntomodulin and glucagon in the gastrointestinal tract and the plasma of the rat.
    Kervran A; Blache P; Bataille D
    Endocrinology; 1987 Aug; 121(2):704-13. PubMed ID: 3595539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioactive enteroglucagon (oxyntomodulin): present knowledge on its chemical structure and its biological activities.
    Bataille D; Gespach C; Tatemoto K; Marie JC; Coudray AM; Rosselin G; Mutt V
    Peptides; 1981; 2 Suppl 2():41-4. PubMed ID: 6283496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of glicentin to proglucagon and glucagon in the porcine pancreas.
    Moody AJ; Holst JJ; Thim L; Jensen SL
    Nature; 1981 Feb; 289(5797):514-6. PubMed ID: 7007887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Enigmatic N-Terminal Domain of Proglucagon; A Historical Perspective.
    Conlon JM
    Front Endocrinol (Lausanne); 2021; 12():683089. PubMed ID: 34177808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic and intestinal processing of proglucagon in man.
    Orskov C; Holst JJ; Poulsen SS; Kirkegaard P
    Diabetologia; 1987 Nov; 30(11):874-81. PubMed ID: 3446554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of glucagon-37 (bioactive enteroglucagon/oxyntomodulin) from porcine jejuno-ileum. Characterization of the peptide.
    Bataille D; Tatemoto K; Gespach C; Jörnvall H; Rosselin G; Mutt V
    FEBS Lett; 1982 Sep; 146(1):79-86. PubMed ID: 7140977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.